AlphaFold predicted structure
F11 · P03951

Mean pLDDT
86.9/ 100
Confident
625 residues
Confidence breakdown
- Very high(≥ 90)64%
- Confident(70–90)25%
- Low(50–70)5%
- Very low(< 50)6%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
coagulation factor XI
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Bleeding and platelet disorders
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomalFactor XI deficiency
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomalInherited bleeding disorders
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomalfactor XI deficiency
congenital factor XI deficiency
venous thromboembolism
deep vein thrombosis
pulmonary embolism
heart disorder
phlebitis
Thrombophlebitis
hereditary angioedema
cardiovascular disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Coagulation factor XI
Factor XI triggers the middle phase of the intrinsic pathway of blood coagulation by activating factor IX
Curated MONDO disease pages that list F11 among their top associated genes.
F11 · P03951

Mean pLDDT
86.9/ 100
Confident
625 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0